RxDoctor Payments Data

Rick Robertson

Psychiatry · Danville, INNPI 1063450807

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $31,246 of the $35,673 with a category attached, or 87.6%. AbbVie accounts for 74.1% of it on its own, with 20 other manufacturers making up the rest. Among psychiatry clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,673in general payments, 2019–2025

Across 204 payments — averaging $174.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$26K
  • Otsuka America Pharmaceutical, Inc.$6K
  • Takeda Pharmaceuticals U.S.A., Inc.$2K
  • Sunovion Pharmaceuticals Inc.$253
  • Lundbeck LLC$194
  • Avanir Pharmaceuticals, Inc.$170
  • plus $847 from 15 others

What the payments were for

  • Speaking & faculty fees$31,24688%
  • Travel & lodging$1,4394%
  • Food & beverage$2,8098%
  • Education$1801%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,673 in reported general payments places this provider in the 95th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana

Other psychiatry in Danville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →